Roche and Genentech Seal the Deal

Roche and Genentech Seal the Deal

Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't al...

Employees Sound Off on the Future of Genentech: 100% Roche?

Employees Sound Off on the Future of Genentech: 100% Roche?

In this week's news, the future of Genentech crept up as word that Roche, a Swiss drug maker which has owned all or majority parts...